Your browser doesn't support javascript.
loading
LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.
Wang, Yi-Shu; Chen, Jianfeng; Cui, Fengmei; Wang, Huibo; Wang, Shuai; Hang, Wei; Zeng, Qinghua; Quan, Cheng-Shi; Zhai, Ying-Xian; Wang, Jian-Wei; Shen, Xiang-Feng; Jian, Yong-Ping; Zhao, Rui-Xun; Werle, Kaitlin D; Cui, Rutao; Liang, Jiyong; Li, Yu-Lin; Xu, Zhi-Xiang.
Afiliación
  • Wang YS; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Chen J; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Cui F; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Wang H; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Wang S; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Hang W; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Zeng Q; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Quan CS; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Zhai YX; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Wang JW; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Shen XF; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Jian YP; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Zhao RX; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
  • Werle KD; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Cui R; Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Liang J; Department of Pharmacology and Experimental Therapeutics, Boston University, School of Medicine, Boston, MA 02118, USA.
  • Li YL; Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Xu ZX; Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, China.
Oncotarget ; 7(45): 73389-73401, 2016 Nov 08.
Article en En | MEDLINE | ID: mdl-27705915
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Daño del ADN / Proteínas Serina-Treonina Quinasas / Resistencia a Antineoplásicos / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Daño del ADN / Proteínas Serina-Treonina Quinasas / Resistencia a Antineoplásicos / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China